waypoint wealth counsel Has $567,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

by · The Cerbat Gem

waypoint wealth counsel lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 21.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,082 shares of the healthcare conglomerate’s stock after buying an additional 191 shares during the quarter. waypoint wealth counsel’s holdings in UnitedHealth Group were worth $567,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of UNH. Brighton Jones LLC grew its holdings in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC grew its holdings in shares of UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after buying an additional 2,324 shares during the period. Bank Pictet & Cie Europe AG grew its stake in UnitedHealth Group by 3.9% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate’s stock valued at $133,373,000 after acquiring an additional 9,872 shares during the period. Crestwood Advisors Group LLC grew its stake in UnitedHealth Group by 6.9% in the fourth quarter. Crestwood Advisors Group LLC now owns 4,147 shares of the healthcare conglomerate’s stock valued at $2,098,000 after acquiring an additional 269 shares during the period. Finally, Impax Asset Management Group plc acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $700,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.6%

Shares of NYSE:UNH opened at $305.59 on Wednesday. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The company has a market capitalization of $277.21 billion, a P/E ratio of 12.80, a price-to-earnings-growth ratio of 1.41 and a beta of 0.44. The company has a 50-day simple moving average of $347.89 and a 200 day simple moving average of $459.15. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the previous year, the business earned $6.91 earnings per share. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.89%. The ex-dividend date was Monday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio (DPR) is currently 37.02%.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn bought 1,533 shares of the company’s stock in a transaction dated Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director now owns 6,033 shares of the company’s stock, valued at $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director John H. Noseworthy acquired 300 shares of the company’s stock in a transaction on Wednesday, May 14th. The stock was acquired at an average price of $312.16 per share, with a total value of $93,648.00. Following the purchase, the director now directly owns 6,063 shares in the company, valued at approximately $1,892,626.08. This represents a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock worth $31,607,768 over the last three months. Insiders own 0.28% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on UNH. HSBC reissued a “reduce” rating and set a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. TD Securities reaffirmed a “hold” rating and issued a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. JPMorgan Chase & Co. upped their price objective on UnitedHealth Group from $405.00 to $418.00 and gave the stock an “overweight” rating in a research report on Friday, June 20th. Truist Financial reaffirmed a “buy” rating and set a $360.00 price objective (down from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Finally, Baird R W downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, June 11th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $427.09.

View Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories